Companies / Elevance Health Inc / Activity
Activity — Elevance Health Inc
63 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Boudreaux Gail CEO | Other | Common Stock | $1.97M | -7K -4.45% | 144,307 0.07% of shares | low |
| Mar 6, 2026 | Kendrick Charles Morgan JR Executive | Sell | Common Stock | $910.6K | -3K -21.33% | 11,791 <0.01% of shares | medium |
| Mar 5, 2026 | Collis Steven H Director | Buy | Common Stock | $869.5K | +3K +469.48% | 3,639 <0.01% of shares | high |
| May 19, 2026 | Penczek Ronald W Executive | Sell | Common Stock | $617.2K | -2K -27.15% | 4,109 <0.01% of shares | medium |
| Mar 3, 2026 | Boudreaux Gail CEO | Other | Common Stock | $493.1K | -2K -1.02% | 169,251 0.08% of shares | low |
| Mar 2, 2026 | Norwood Felicia F Executive | Other | Common Stock | $417.9K | -1K -4.45% | 30,518 0.01% of shares | low |
| Mar 2, 2026 | Kendrick Charles Morgan JR Executive | Other | Common Stock | $356.1K | -1K -11.97% | 8,905 <0.01% of shares | low |
| Mar 2, 2026 | Haytaian Peter D Executive | Other | Common Stock | $353.2K | -1K -4.62% | 24,803 0.01% of shares | low |
| May 19, 2026 | Penczek Ronald W Executive | Exercise | Common Stock | $273.2K | +877 +18.41% | 5,640 <0.01% of shares | low |
| May 19, 2026 | Penczek Ronald W Executive | Exercise | Common Stock | $177.4K | +654 +15.92% | 4,763 <0.01% of shares | low |
| Jun 12, 2026 | Penczek Ronald W Executive | Sell | Common Stock | $148.8K | -369 -8.98% | 3,740 <0.01% of shares | medium |
| Mar 3, 2026 | Norwood Felicia F Executive | Other | Common Stock | $140.9K | -496 -1.26% | 38,838 0.02% of shares | low |
| Mar 3, 2026 | Kendrick Charles Morgan JR Executive | Other | Common Stock | $132.6K | -467 -3.02% | 14,987 <0.01% of shares | low |
| Mar 3, 2026 | Haytaian Peter D Executive | Other | Common Stock | $126.7K | -446 -1.61% | 27,222 0.01% of shares | low |
| Mar 3, 2026 | Wessling Erin M Executive | Other | Common Stock | $118.4K | -417 -5.22% | 7,579 <0.01% of shares | low |
| Mar 3, 2026 | Kaye Mark Executive | Other | Common Stock | $100.3K | -353 -1.09% | 32,037 0.01% of shares | low |
| Feb 2, 2026 | Craig Ryan R Executive | Other | Common Stock | $95.4K | -279 -6.47% | 4,032 <0.01% of shares | low |
| Mar 2, 2026 | Lavu Ratnakar Executive | Other | Common Stock | $92.6K | -315 -6.59% | 4,468 <0.01% of shares | low |
| Mar 3, 2026 | Craig Ryan R Executive | Other | Common Stock | $87.8K | -309 -4.42% | 6,674 <0.01% of shares | low |
| Mar 2, 2026 | Kaye Mark Executive | Other | Common Stock | $79.7K | -271 -1.69% | 15,811 <0.01% of shares | low |
| Mar 3, 2026 | Lavu Ratnakar Executive | Other | Common Stock | $63.1K | -222 -1.36% | 16,149 <0.01% of shares | low |
| Jun 11, 2026 | Dixon Robert L JR Director | Sell | Common Stock | $60.7K | -151 -1.39% | 10,734 <0.01% of shares | low |
| Mar 2, 2026 | Penczek Ronald W Executive | Other | Common Stock | $38.5K | -131 -6.99% | 1,743 <0.01% of shares | low |
| Mar 3, 2026 | Penczek Ronald W Executive | Other | Common Stock | $10.5K | -37 -0.89% | 4,099 <0.01% of shares | low |
| Mar 12, 2026 | Schulman Amy W Director | Sell | Common Stock | $7.5K | -26 -10.66% | 218 <0.01% of shares | low |
| Mar 2, 2026 | Craig Ryan R Executive | Other | Common Stock | $7.4K | -25 -0.62% | 4,007 <0.01% of shares | low |
| May 13, 2026 | Jallal Bahija Director | Grant | Common Stock | $0 | +563 +11.76% | 5,351 <0.01% of shares | low |
| May 13, 2026 | Neri Antonio F Director | Grant | Common Stock | $0 | +563 +11.43% | 5,488 <0.01% of shares | low |
| May 13, 2026 | Strable-Soethout Deanna D Director | Grant | Common Stock | $0 | +563 +34.20% | 2,209 <0.01% of shares | low |
| May 13, 2026 | DeVore Susan D. Director | Grant | Common Stock | $0 | +563 +16.08% | 4,065 <0.01% of shares | low |
| May 13, 2026 | Dixon Robert L JR Director | Grant | Common Stock | $0 | +563 +5.45% | 10,885 <0.01% of shares | low |
| May 13, 2026 | Schulman Amy W Director | Grant | Common Stock | $0 | +563 +258.26% | 781 <0.01% of shares | low |
| May 13, 2026 | Schneider Ryan M. Director | Grant | Common Stock | $0 | +563 +8.53% | 7,163 <0.01% of shares | low |
| May 13, 2026 | Peru Ramiro G Director | Grant | Common Stock | $0 | +563 +6.02% | 9,908 <0.01% of shares | low |
| May 13, 2026 | Collis Steven H Director | Grant | Common Stock | $0 | +563 +15.47% | 4,202 <0.01% of shares | low |
| May 13, 2026 | Hay Lewis III Director | Grant | Common Stock | $0 | +563 +4.89% | 12,070 <0.01% of shares | low |
| Mar 2, 2026 | Kaye Mark Executive | Grant | Common Stock | $0 | +10K +45.98% | 32,390 0.01% of shares | low |
| Mar 2, 2026 | Kaye Mark Executive | Grant | Common Stock | $0 | +6K +40.33% | 22,188 0.01% of shares | low |
| Mar 2, 2026 | Norwood Felicia F Executive | Grant | Common Stock | $0 | +3K +7.86% | 39,334 0.02% of shares | low |
| Mar 2, 2026 | Norwood Felicia F Executive | Grant | Common Stock | $0 | +6K +19.50% | 36,469 0.02% of shares | low |
| Mar 2, 2026 | Lavu Ratnakar Executive | Grant | Common Stock | $0 | +7K +71.08% | 16,371 <0.01% of shares | low |
| Mar 2, 2026 | Lavu Ratnakar Executive | Grant | Common Stock | $0 | +5K +114.17% | 9,569 <0.01% of shares | low |
| Mar 2, 2026 | Penczek Ronald W Executive | Grant | Common Stock | $0 | +266 +6.87% | 4,136 <0.01% of shares | low |
| Mar 2, 2026 | Penczek Ronald W Executive | Grant | Common Stock | $0 | +2K +78.42% | 3,870 <0.01% of shares | low |
| Mar 2, 2026 | Penczek Ronald W Executive | Grant | Common Stock | $0 | +426 +24.44% | 2,169 <0.01% of shares | low |
| Mar 2, 2026 | Haytaian Peter D Executive | Grant | Common Stock | $0 | +3K +11.55% | 27,668 0.01% of shares | low |
| Feb 2, 2026 | Schulman Amy W Director | Grant | Common Stock | $0 | +218 | 218 <0.01% of shares | low |
| Mar 2, 2026 | Boudreaux Gail CEO | Grant | Common Stock | $0 | +11K +6.56% | 170,987 0.08% of shares | low |
| Mar 2, 2026 | Boudreaux Gail CEO | Grant | Common Stock | $0 | +16K +11.19% | 160,460 0.07% of shares | low |
| Mar 2, 2026 | Wessling Erin M Executive | Grant | Common Stock | $0 | +3K +59.28% | 7,996 <0.01% of shares | low |